Non-viral gene therapy that targets motor neurons in vivo
A major challenge in neurological gene therapy is safe delivery of transgenes to sufficient cell numbers from the circulation or periphery. This is particularly difficult for diseases involving spinal cord motor neurons such as amyotrophic lateral sclerosis (ALS). We have examined the feasibility of...
Main Authors: | Mary-Louise eRogers, Kevin Sean Smith, Dusan eMatusica, Matthew eFenech, Lee eHoffman, Robert Archer Rush, Nicolas Hans Voelcker |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2014-10-01
|
Series: | Frontiers in Molecular Neuroscience |
Subjects: | |
Online Access: | http://journal.frontiersin.org/Journal/10.3389/fnmol.2014.00080/full |
Similar Items
-
Development of non-viral vehicles for targeted gene transfer into microglia via the integrin receptor CD11b
by: Markus eSmolny, et al.
Published: (2014-10-01) -
Echogenic PEGylated PEI-Loaded Microbubble As Efficient Gene Delivery System
by: Liufu C, et al.
Published: (2019-11-01) -
Effects of Reactive Oxygen and Nitrogen Species on TrkA Expression and Signalling: Implications for proNGF in Aging and Alzheimer’s Disease
by: Erika Kropf, et al.
Published: (2021-08-01) -
Upregulation of p75NTR by Histone Deacetylase Inhibitors Sensitizes Human Neuroblastoma Cells to Targeted Immunotoxin-Induced Apoptosis
by: Simona Dedoni, et al.
Published: (2022-03-01) -
The p75 neurotrophin receptor in AgRP neurons is necessary for homeostatic feeding and food anticipation
by: Brandon Podyma, et al.
Published: (2020-01-01)